Publications
-
Number of applications for individual reimbursement of medicines in 2010
| 14 June 2011 |
In 2010, we reached decisions in a total of 144,324 individual reimbursement applications against 138,714 in 2009, corresponding to an increase of 4 %. The figure breaks down to approx. 96,000 applications for single reimbursement (about 3 % fewer than in 2009), approx. 34,000 applications for reimbursement for the chronically ill (about 30 % more than in 2009), approx. 12,000 applications for reimbursement for the terminally ill (about 7 % more than in 2009) and approx. 2,800 applications for increased reimbursement (about 14 % more than in 2009).
-
Report on the blood product area in 2009
| 17 August 2010 |
In 2009, 358.000 blood collections were made in Denmark. This is approximately 4.000 collections more than the previous year. Moreover, approximately 332.000 units of red blood cells (erythrocytes) were used in connection with blood transfusions in 2009.
-
Product defects and withdrawal of medicinal products in 2006
| 26 July 2007 |
In 2006 there were more reports on product defects compared with 2005. The reports concerned both marketed and non-marketed medicinal products. including magistral medicinal products which are manufactured according to a doctor's directions.
-
Report on the blood product area in 2008
| 02 September 2009 |
The blood product report is published every year based on figures from the Danish blood centres and the Blood-donors in Denmark.
-
Report on action against the sale of illegal medicinal products on the internet
| 22 December 2006 |
In November/December 2006, the Danish Medicines Agency carried out an internet action against the illegal sale of medicinal products over the internet. The action primarily focused on potency and diet products.
-
Account of the blood product area in 2005
| 21 September 2006 |
The account contains figures about the collection of blood from donors and the use of the blood collected. The account is published annually based on figures from blood centres and the Blood-donors in Denmark.
-
Annual Pharmacovigilance Report 2016 of the Danish Medicines Agency
| 08 June 2017 |
The number of reports on suspected adverse reactions submitted to the DKMA in 2016 more or less levelled the year before. We received less ADR reports from physicians, but ADR reports involving patien
-
Clinical trials of medicines - Annual report 2015
| 09 August 2016 |
Last year, the Danish Medicines Agency received 329 applications for authorisation of clinical trials of medicines in humans – 45 applications more than in 2014. The figures appear from the Danish Medicines Agency’s annual report on clinical trials.
-
Our strategy 2017-2021
| 15 December 2016 |
The Danish Medicines Agency: Among Europe's best in class! This is the title of our strategy for 2017-2021, which emphasises our commitment to both public health and growth in Denmark.
-
Annual report 2013 clinical trials of medicines in humans
| 03 July 2014 |
The Danish Health Authority's has published its annual report 2013 on clinical trials of medicines in humans.
-
Market surveillance project 2014 - Inspection of dental laboratories and analyses of fixed dental prosthetics
| 24 July 2015 |
The Danish Health Authority carried out 16 inspections of dental laboratories in 2014 and presents the results of the project in this market surveillance report. The purpose of the project was to ex
-
Adverse drug reaction reports (ADRs) from consumers may improve patient safety
| 20 March 2013 |
In a report, the DHMA has reviewed the ADR reports received during the years 2003–2011 to clarify how consumer reports differ from reports from healthcare professionals.